Publications by authors named "Bruce R Conway"

13Publications

Indole-glucosides as novel sodium glucose co-transporter 2 (SGLT2) inhibitors. Part 2.

Bioorg Med Chem Lett 2006 Mar 27;16(6):1696-701. Epub 2005 Dec 27.

Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 1000 Rt. 202, PO Box 300, Raritan, NJ 08869, USA.

View Article and Find Full Text PDF
March 2006

Heteroaryl-O-glucosides as novel sodium glucose co-transporter 2 inhibitors. Part 1.

Bioorg Med Chem Lett 2005 Dec 28;15(23):5202-6. Epub 2005 Sep 28.

Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 1000 Rt. 202, PO Box 300, Raritan, NJ 08869, USA.

View Article and Find Full Text PDF
December 2005

Synthesis and evaluation of 3-anilino-quinoxalinones as glycogen phosphorylase inhibitors.

Bioorg Med Chem Lett 2005 Nov;15(21):4790-3

Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 1000 Rt. 202, PO Box 300, Raritan, NJ 08869, USA.

View Article and Find Full Text PDF
November 2005

Glycosylated dihydrochalcones as potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitors.

Bioorg Med Chem Lett 2004 Oct;14(20):5121-5

Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 1000 Rt. 202, PO Box 300, Raritan, NJ 08869, USA.

View Article and Find Full Text PDF
October 2004

Human cardiomyocytes express high level of Na+/glucose cotransporter 1 (SGLT1).

J Cell Biochem 2003 Oct;90(2):339-46

Endocrine Therapeutics and Metabolic Disorders Team, Drug Discovery, Johnson & Johnson Pharmaceutical Research and Development, LLC., Raritan, New Jersey 08869, USA.

View Article and Find Full Text PDF
October 2003

The use of biosensors to study GPCR function: applications for high-content screening.

Recept Channels 2002 ;8(5-6):331-41

Department of Drug Discovery, R. W. Johnson Pharmaceutical Research Institute, Raritan, New Jersey, USA.

View Article and Find Full Text PDF
June 2003